Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
International Journal of Antimicrobial Agents
|
August 8, 2017
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
Patrick N A Harris, M Diletta Pezzani, Belén Gutiérrez-Gutiérrez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial
Laura Muñoz, Miguel Santin, Fernando Alcaide, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2016
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
Belén Gutiérrez-Gutiérrez, Robert A Bonomo, Yehuda Carmeli, et al.
Infection Control and Hospital Epidemiology
|
April 6, 2018
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Oded Scheuerman, Vered Schechner, Yehuda Carmeli, et al.
Nature Medicine
|
October 2, 2023
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
Sara Grillo, Miquel Pujol, Josep M Miró, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2016
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Belén Gutiérrez-Gutiérrez, Salvador Pérez-Galera, Elena Salamanca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Esther Calbo, et al.
Infectious Diseases and Therapy
|
March 2, 2025
Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial
Guillermo Cuervo, Marta Hernández-Meneses, Arístides de Alarcón, et al.
Microbiology Spectrum
|
April 27, 2022
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
Alba Bergas, Adaia Albasanz-Puig, Ana Fernández-Cruz, et al.
The Journal of Antimicrobial Chemotherapy
|
January 8, 2017
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Marina De Cueto, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
International Journal of Antimicrobial Agents
|
August 8, 2017
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
Patrick N A Harris, M Diletta Pezzani, Belén Gutiérrez-Gutiérrez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial
Laura Muñoz, Miguel Santin, Fernando Alcaide, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2016
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
Belén Gutiérrez-Gutiérrez, Robert A Bonomo, Yehuda Carmeli, et al.
Infection Control and Hospital Epidemiology
|
April 6, 2018
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Oded Scheuerman, Vered Schechner, Yehuda Carmeli, et al.
Nature Medicine
|
October 2, 2023
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
Sara Grillo, Miquel Pujol, Josep M Miró, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2016
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Belén Gutiérrez-Gutiérrez, Salvador Pérez-Galera, Elena Salamanca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Esther Calbo, et al.
Infectious Diseases and Therapy
|
March 2, 2025
Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial
Guillermo Cuervo, Marta Hernández-Meneses, Arístides de Alarcón, et al.
Microbiology Spectrum
|
April 27, 2022
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
Alba Bergas, Adaia Albasanz-Puig, Ana Fernández-Cruz, et al.
The Journal of Antimicrobial Chemotherapy
|
January 8, 2017
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Marina De Cueto, et al.
Page
of 6